Since at least WWII, some open contaminated wounds involving massive soft tissue injury and vascular damage have resulted in "irreversible shock," despite prompt rescue, hemorrhage control, and blood and fluid replacement, without signs of clinical infection.
Introduction
During World War I, World War II (WWII), the Korean conflict, and in peacetime accidents, there have been instances of patients with open, contaminated, soft-tissue injuries and vascular damage who died in "irreversible shock" despite prompt hemostasis and fluid and blood replacement and no obvious clinical infection. 1, 2 Research studies on anesthetized goats with massive, naturally multicontaminated, explosive wounds of the thigh, produced similar conditions always with fatal results. 1, 3 These studies indicated that the survival time was related statistically only to the dosage of Clostridium perfringens in these multi-contaminated wounds. 3 Death probably resulted from C. perfringens toxemia prior to the development of clinical signs of gas gangrene. To verify this etiology, it was necessary to find a method to control the C. perfringens without any other therapy.
Many topical antibacterial agents were tested, and some were associated with prolonged survival time in that delayed amputation permitted survival of the animal, 4 but only one agent enabled complete control of the infection and complete recovery of the animal without surgical intervention. This was mafenide hydrochloride aqueous spray. The necrotic tissue applied three times daily to deep partial thickness and full thickness burns, after initial cleansing and superficial debridement (usually on the ward), and also into deep open wounds. The wounds and burns were left open, permitting the formation of a thin protective film, and dressings rarely needed. Although mafenide hydrochloride kills bacteria immediately on contact, the repeated treatment was done in case some bacteria had not been reached initially. The devascularized tissue and full thickness burns remained uninfected, so the full thickness burns could be removed electively as partial thickness burns were healing, thus providing more skin for autogenous grafts, and improving the patient's general nutrition and mobility. 11
Discussion
Based on this evidence, it now is time for current action to revisit the use of mafenide hydrochloride aqueous spray for the initial management of severe, contaminated wounds and deep burns, especially when there is impaired blood supply and possible presence of anaerobic organisms. Mafenide hydrochloride is a stronger antibacterial agent than is mafenide acetate. 12, 13 The severe wounds and deep burns usually also have impaired sensation. If the spray unintentionally reaches a less severe injury, such as a superficial burn, it may cause a brief stinging sensation.
Mafenide hydrochloride solution spray passes rapidly through necrotic tissue, including full thickness burns, immediately exerting its antibacterial effect without dependence on blood supply. The mafenide then is rapidly metabolized and rapidly eliminated without any known side effects. 14 The film formed from interaction with wound fluid minimizes need for dressings. Continuous wet dressings are contraindicated, as would be additional substances to slow the elimination of the mafenide, because of the reduction of its chemical antibacterial effect.
Mafenide hydrochloride powder is available and it easily is made into an aqueous solution, preferably using sterile distilled water-5% for the face, otherwise 5% or 10%. It can be transported in simple spray containers for field use.
As soon as any severe bleeding is controlled, the wound or burn is sprayed with the mafenide hydrochloride solution. If needed to prevent additional trauma during rescue, the wounds or burns are covered with dry sterile pads or towels. 15 When possible, the wounds or burns then are left open and sprayed at least once a day, but preferably three times daily. As was seen in the Vietnam study, the solution interacts with the tissue surface to form a protective film. This enables visualization of the wound or burn, easy mobility of the patient, and minimizes the amount of dressings and nursing care. The tissue remains free of clinical infection. The repeated use of the spray is recommended in case some of the bacteria were not reached initially in large deep wounds. Surgical procedures, such as excision and grafting of full thickness burns and removal of obviously necrotic tissue, can be done electively, as the more shallow wounds or more superficial burns are healing and as the patient's general condition improves.
Since 1969, Sulfamylon cream has been made of mafenide acetate. Mafenide hydrochloride solution was available from a pharmaceutical through about 1971. Since developed no clinical infection and sloughed, leaving healthy tissue beneath, so the large wound healed spontaneously. 5 The mafenide hydrochloride spray also removed the Pseudomonas aeruginosa in the goat wounds. An investigator of burn injuries verified the capability of aqueous mafenide hydrochloride to pass through intact, devascularized skin, and then successfully utilized aqueous mafenide hydrochloride spray in the treatment of a small group of burn patients. 6 American studies conducted during WWII led to the doctrine that initial topical application of antibacterial agents to severe, contaminated wounds was of little value, and even could be detrimental. Immediate thorough surgical debridement was recommended as the only valuable initial treatment of the wounds. 7, 8 This recommendation was based on studies using mostly sulfanilamide derivatives such as sulfathiazole, sulfapyridine, and sulfadiazine, which now are known to be inhibited in these wounds by wound fluids, pus, and the p-aminobenzoic acid (PABA) in the wounds. 9 During the same time period (WWII), the Germans were providing their soldiers with packets containing some of these agents, but also mafenide hydrochloride powder to prevent gas gangrene. 9 Apparently, American investigators had not studied the potential value of topical mafenide hydrochloride to control anaerobic organisms in contaminated wounds with vascular impairment. Although mafenide is a sulfonamide drug, unlike the others, it is not inhibited by PABA, wound fluids, or pus. Mafenide hydrochloride is 4-(amino methyl) benzene sulfonamide hydrochloride, also called homo-sulfanilamide hydrochloride. It was first synthesized in Germany and patented in 1939 as "Marfanil." It originated in the United States in about 1940, with the trade name "Sulfamylon". 9 Mafenide hydrochloride was marketed as Sulfamylon for topical antibacterial therapy since 1950. There were suppositories, gels, and other preparations. Five percent aqueous Sulfamylon hydrochloride solution was available through 1966. The virtual abandonment of further interest in mafenide hydrochloride may have been accelerated by the widely quoted statement of Siebenmann and Plummer (1945) that "penicillin is about 60 times more effective against C. welchii than Marfanil." Apparently no one noted that this conclusion was prefaced by "on a weightper-weight basis, under conditions of this experiment." These authors had stated that in early local treatment of Clostridium welchii (C. perfringens) infections in mice, "it was found that of all the sulfonamides tested, Marfanil is the most active." 10 With knowledge of these studies, in 1970-1971, topical Sulfamylon was found to be effective in the management of about 200 Vietnamese military patients with burns and combat injuries in a "chronic mass casualty" environment. There were only 17 deaths, none attributed to wound infection. There were no deaths in the last 110 patients, when all aspects of the recommended patient care were utilized. Both the commercial Sulfamylon acetate cream (water soluble ointment) and mafenide hydrochloride powder to be made into 5% or 10% aqueous solution were available, but preference soon was made for use of the aqueous mafenide hydrochloride solution applied as a spray. The spray was Mafenide hydrochloride powder has a logistic advantage when space for transport and storage of supplies is limited. Fifty milliliters of the solution will cover approximately 50% of the body surface of an average-sized man. It can be estimated that 5 pounds of the powder yields enough 10% aqueous spray to cover 50% of the body surface of approximately 455 persons or enough 5% solution spray to cover 50% of the body surface of about 910 persons.
Conclusion
Earlier studies support that mafenide hydrochloride solution spray is an effective topical antibacterial agent. It penetrates devitalized tissue exerting immediate antibacterial effects, especially against the potentially lethal C. perfringens and Pseudomonas aeruginosa. Based on the evidence, it is recommended that research on the use of mafenide hydrochloride solution spray be revisited for the easy and effective initial management of severely contaminated wounds and burns.
1998, Sulfamylon was acquired by another pharmaceutical company, and only mafenide acetate cream and mafenide acetate powder to be made into solution are patented and sold as "Sulfamylon." In the 2001 Physicians' Desk Reference (PDR), the description of the purpose, use, and problems of mafenide acetate differs from the methods and values in the use of the hydrochloride preparation noted in this report. 16, 17 However, for initial management of severe contaminated wounds and deep burns, mafenide hydrochloride powder can be purchased from any of several chemical companies, and can be made into the mafenide hydrochloride solution by addition to sterile water. This process is preferable for emergency medicine because the mafenide hydrochloride powder can be transported easily to the central supply location, where it can be made into the desired strength-5 or 10% solution-and placed temporarily into unbreakable, large containers or directly into the smaller spray containers (25-50 ml., depending on the circumstances).
